Nuvisan

🎉 We are proud to be part of the CARE (Corona Accelerated R&D in Europe) projects. CARE is the largest European research initiative addressing the challenges of COVID-19 and striving in anti-viral drug development. With other CARE partners, our collaborative efforts have now achieved an in vivo proof-of-concept and the project is moved into lead optimization phase. #covid19 #CAREvsCOVID #careconsortium #NUVISAN #drugdiscovery

📢 Our Human iPSC Platform flyer is OUT!    Discover NUVISAN's portfolio of advanced 2D and 3D human induced pluripotent stem cell (iPSC) models!     Our human iPSC platform can differentiate into various cell lineages, perform CRISPR genome editing and assess the transcriptome of iPSC-derivatives with our in-house NGS expertise. We also offer customized automated 2D and 3D assays enabling high-throughput screens to help you identify the most promising drug candidates.  Our platform strives to deliver robust and reproducible results for comprehensive target validation and endeavours to ensure that your scientific journey is crowned with success. Interested? Check out our flyer here: https://lnkd.in/gpPTqQj2 or get in touch with Norman Liaw, Head of iPSC Platform to start your journey with us 🧠   #NUVISAN #iPSCs #NGS #HighThroughputScreens #DrugDiscovery

🚀 It’s a wrap for NUVISAN's Our Science series! As our Science Series comes to a close after a wonderful couple of months, we want to take a moment to reflect on the journey we've shared. Throughout this series, we have delved into various fascinating topics and explored groundbreaking discoveries. We hope that each post has sparked your curiosity, and perhaps even inspired a deeper interest in the sciences. It has been our pleasure to bring you engaging content and insightful discussions. While our Science Series may be concluding, our commitment to delivering informative and captivating content continues. Stay tuned for more exciting topics and updates! 🤝 💫 🚀 Impurity Profiling: https://lnkd.in/eDysdwsm 💻 Bioinformatic Analysis: https://lnkd.in/eJwH6sHA 🚀 Single Cell RNA-sequencing: https://lnkd.in/ewkhnCmT 🌈 Spectral Flow Cytometry: https://lnkd.in/efwMvFr8 🎯 Targeted Protein Degradation (TPD): https://lnkd.in/eb-e-pYF 🚀 Organoids as a new tool for drug screening: https://lnkd.in/eVygivqK 🎨  Cell Painting: https://lnkd.in/esWNMirX 📯 NUVISAN's Game-Changing Compound Libraries: https://lnkd.in/etMX6Uhr 🚀 Developmental Metabolite Identification - Part II: https://lnkd.in/eAi6hEkn 💊 eSource Data Collection in Clinical Trials: https://lnkd.in/ewa9pKfZ 💊 Developmental Metabolite Identification - Part I: https://lnkd.in/exkZ7UHB 🔬 Revolutionizing Therapeutics with LNPs: https://lnkd.in/ec2hNyeJ 🔬 In vitro drug release test (IVRT) solutions: https://lnkd.in/emuzjD8z 🚀 Pinpoint your drug candidate´s CYP450 induction potential: https://lnkd.in/ehEB2y_y 🚀 Cryo-Electron Microscopy(Cryo-EM): https://lnkd.in/ewGvngEJ #OurScience #NUVISAN #theScienceCRO #drugdiscovery #drugdevelopment

We are delighted to be engaging with numerous globally renowned research institutions and pharmaceutical companies in the impactful and exciting CARE Consortium projects. 📯 We are thrilled to share insights into CARE Consortium Work Package 3, which focuses on antiviral drug development from hits to leads. #covid19 #CAREvsCOVID #careconsortium #NUVISAN #drugdiscovery

📢 We are at ISSCR 2024! We are excited to be part of the most comprehensive gathering in stem cell research—ISSCR 2024 from today until Saturday. Our colleagues Norman Liaw, Claudia Noack, Skadi Lau, Maike Marczenke, and Krzysztof Brzezinka look forward to connecting with you to introduce our NUVISAN iPSC platform and explore potential collaborations. 🤝 Stop by our booth (#502) and chat with us! 📅 Also, don’t forget to join Norman’s talk at the Exhibit Hall Theater H on July 12, from 16:20 to 16:35. #ISSCR2024 #ipscs #stemcell #diseasemodeling #compoundscreening

We Cycle for a better Climate! 🚴♂️ We are delighted to have more colleagues involved in CITY CYCLING this year! By participating in this initiative, we're enhancing our health and well-being, reducing carbon emissions, and contributing to cleaner, greener cities. Together, we're fostering a healthier lifestyle for ourselves and a healthier planet for future generations. Our highlights: 🌱 20,820 kilometers covered: Together, we covered an impressive distance, saving 3,456.2 kilograms of CO2 as a result! 💪 Team spirit and health: Our participation not only improved our fitness but also strengthened our team spirit. It was truly inspiring to see everyone's motivation and commitment. Let's keep pushing those pedals to support sustainable mobility and a healthier planet. 🌍🌱 #Stadtradeln #CITYCYCLING #climateprotection #sustainability #strongtogether #teamwork

It was such a great experience to participate in the Long Night of the Sciences and to meet all of the enthusiastic little scientists 👨🔬 👩🔬 It's a wrap! That was the Long Night of the Sciences 2024! 🤝 At our partner Campus Berlin-Buch GmbH in the Mensa on June 22, our visitors made fascinating slime with household materials. 💡🔬 Did you miss it? Browse through our photo gallery and make sure you continually follow us on LinkedIn so you won't miss out on our next fun experiment! #science #LNDW #experiments #NUVISAN

🤝 ALS‘s Strategic Acquisition Drives Innovation and Science! As part of our commitment to growth and efficiency, effective April 1, the global leader in testing, ALS Limited, took full ownership of NUVISAN. This strategic acquisition extends our high-quality and personalized solutions to post-commercialization and multiple locations worldwide, presenting specific opportunities for our customers. 👀 Take a look at what our colleagues think about the acquisition and the exciting potential for the future -> https://lnkd.in/eB7uJQ8z #NUVISAN #ALS #acquisition #science #innovation #drugdiscovery #drugdevelopment

👨🏻🏫 Join NUVISAN for a talk about human iPSCs on July 12 at the upcoming ISSCR Annual Meeting 2024!   Induced pluripotent stem cells (iPSCs) hold promise for regenerative medicine, drug screening and discovery, and advanced therapeutic medicinal products. At NUVISAN, we understand the intricacies of working with state-of-the-art methodologies to maximally leverage iPSCs in 2D and 3D model systems, and thrive in collaborative partnerships where we act as your scientific sparring partner to bring your research to the forefront.   Norman Liaw, the Head of the iPSC Platform and Senior Scientist at NUVISAN will share some insights on how we work to bring your bright idea, drug candidate or advanced project towards clinical translation whilst implementing human iPSCs in your drug discovery journey. Join us at the Exhibit Hall Theater H at the upcoming ISSCR 2024 in Hamburg, Germany on July 12, from 16:20 to 16:35.   🌈 Interested in having a more intimate chat with us and to pick up some free goodies? Don’t miss the chance to join Norman Liaw and our NUVISAN experts Claudia Noack, Skadi Lau, Maike Marczenke, and Krzysztof Brzezinka at Booth 502. 💬 Schedule a meeting with us now: https://lnkd.in/eBGAuwPG or swing by at any time throughout the conference. We look forward to meeting you!   #StemCell #StemCellResearch #iPSC #Organoids #3DModeling #DiseaseModeling #HTS #Screening #Regeneration #RegenerativeMedicine #Science #ISSCR2024

🚀 Our Science at NUVISAN: Cryo-Electron Microscopy(Cryo-EM) Here at NUVISAN, we combine our in-house protein science and cryo-electron microscopy (cryo-EM) expertise to deliver structures of your challenging pharmaceutical targets and enable structure-based drug discovery. In the world of cryo-EM, protein quality is key! Our team is specialized in preparing high quality GPCRs, ion channels, protein-nucleic acid complexes, and antibody-antigen complexes for cryo-EM. 👍 Fresh-is-best – Our same-site labs allow us to use freshly purified samples directly for grid preparation, thereby bypassing unnecessary freezing steps and significantly enhancing our success rates. In a recent project our Nuvisan protein production and cryo-EM experts successfully purified a Fab-bound A2A GPCR and determined the 3.4 Å cryo-EM structure of the GPCR complex in its inactive state. 💬 For more detailed insights on how we can support your projects connect with our cryo-EM team lead Alexander Ulrich or visit our webpage: https://lnkd.in/eC2rSKed #OurScience #cryoEM #proteinstructure #GPCR #membraneproteins #drugdiscovery #structuralbiology #proteintechnologies #ionchannels #theScienceCRO